Clinical Trials Directory

Trials / Unknown

UnknownNCT02263196

The Efficacy of Alcohol After Betadine and Combination of Alcohol and Betadine on Inflammation Vascular Access

Mashhad University of Medical Sciences

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
96 (estimated)
Sponsor
Mashhad University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to compare the efficacy of combination of alcohol and povidone iodine 10% and Alcohol 70% after povidone iodine 10% on inflammation and infection related to vascular access area in hemodialysis patients.

Detailed description

These cases were identified from patient that lack of specific diseases; Non-use of antibiotics or immunosuppressive drugs. That the participants will be selected using convenience sampling method and randomly divided into three groups: combination of alcohol and povidone iodine 10%, Alcohol after and control groups. In the Intervention in one group the vascular access site disinfected with Alcohol(group1) and in group 2, Alcohol and povidone iodine 10% was used to separate were disinfected. Then the patient in a month of inflammation and infection of the vascular access will be monitor. Exclusion criteria: inflammation or fistula failure during the study for any reason other than infection. Sample size determination: Through the pilot study. Date: 02.10.2014 till 02.11.2014 Outcome: Washing with both solution affected on reduce the inflammation and infection of the patient. the efficacy of Alcohol after Betadine and combination of alcohol and Betadine on inflammation and infection related to Vascular access hemodialysis patients.

Conditions

Interventions

TypeNameDescription
OTHERAlcohol and povidone iodineusing from Alcohol and povidone iodine for prevention of inflammation
OTHERcombination of alcohol and betadinusing from combination Alcohol and povidone iodine for prevention of inflammation

Timeline

Start date
2014-09-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2014-10-13
Last updated
2015-04-08

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT02263196. Inclusion in this directory is not an endorsement.